Viatris (VTRS) Free Cash Flow (2019 - 2026)
Viatris (VTRS) recorded quarterly Free Cash Flow of $348.4 million in Q1 2026, down 43.74% quarter-over-quarter from $619.3 million in Q4 2025, and down 29.32% on a YoY basis from $492.9 million in Q1 2025.
Viatris (VTRS) Free Cash Flow (2019 - 2026) Analysis & Trends
Viatris' Free Cash Flow history runs 8 years deep, the most recent figure standing at $348.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 29.32% year-over-year to $348.4 million; the TTM figure through Mar 2026 stood at $1.8 billion (down 5.9% YoY), while the FY2025 annual figure was $1.9 billion, down 2.01% from the prior year.
- Free Cash Flow was $348.4 million for Q1 2026 at Viatris, down from $619.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.1 billion in Q1 2022 to a low of $35.3 million in Q4 2022.
- Historically, Free Cash Flow has averaged $551.7 million across 5 years, with a median of $564.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 89.16% in 2022, then surged 1041.64% in 2023.
- A 5-year view of Free Cash Flow shows it stood at $35.3 million in 2022, then soared by 1041.64% to $403.0 million in 2023, then dropped by 15.06% to $342.3 million in 2024, then jumped by 80.92% to $619.3 million in 2025, then plunged by 43.74% to $348.4 million in 2026.
- The last three Free Cash Flow figures came in at $348.4 million (Q1 2026), $619.3 million (Q4 2025), and $658.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 348.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 348.40 Mn |
| Mar 31, 2026 | 348.40 Mn |
| Dec 31, 2025 | 619.30 Mn |
| Dec 31, 2025 | 619.30 Mn |
| Sep 30, 2025 | 658.10 Mn |
| Sep 30, 2025 | 658.10 Mn |
| Jun 30, 2025 | 166.80 Mn |
| Jun 30, 2025 | 166.80 Mn |
| Mar 31, 2025 | 492.90 Mn |
| Mar 31, 2025 | 492.90 Mn |
| Dec 31, 2024 | 342.30 Mn |
| Dec 31, 2024 | 342.30 Mn |
| Sep 30, 2024 | 749.50 Mn |
| Sep 30, 2024 | 749.50 Mn |
| Jun 30, 2024 | 320.30 Mn |
| Jun 30, 2024 | 320.30 Mn |
| Mar 31, 2024 | 564.80 Mn |
| Mar 31, 2024 | 564.80 Mn |
| Dec 31, 2023 | 403.00 Mn |
| Dec 31, 2023 | 403.00 Mn |